Plain-English translation of NCT06775028 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
AFFIRMO is testing a new way to care for older adults (65+) who have atrial fibrillation—an irregular heartbeat—along with other health conditions like high blood pressure, diabetes, or heart disease. Some patients will receive a personalized care program called iABC that includes education, dietary guidance, exercise recommendations, and close monitoring. Others will receive usual care as normally provided at their hospital or clinic.
Older patients with atrial fibrillation often have multiple other health problems, making their care complicated. This trial is designed to see whether a structured, personalized approach—rather than standard care—can better prevent complications like stroke and improve quality of life in these vulnerable patients.
You likely qualify if…
You likely don't qualify if…
Half of the participating hospitals will use the new iABC personalized care approach, while the other half will provide usual care. If you are in the iABC group, you will receive education about your heart condition, guidance on diet and exercise, and regular check-ins where your doctor reviews data you provide and may adjust your medications or lifestyle plan. All participants will be followed for about a year, with periodic visits and assessments to track your health and prevent complications.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
Bulgaria